Literature DB >> 27371132

Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: A frequent association?

A Chardain1, V Mesnage2, S Alamowitch2, F Bourdain3, S Crozier4, T Lenglet5, D Psimaras5, S Demeret6, P Graveleau3, K Hoang-Xuan5, R Levy2.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a serious neurological condition encountered in various medical fields. Pathophysiological factor(s) common to PRES cases of apparently unrelated etiologies are yet to be found. Based on the hypothesis that hypomagnesemia might participate in the cascade leading to PRES, our study sought to verify whether hypomagnesemia is frequently associated with PRES regardless of etiology. From a retrospective study of a cohort of 57 patients presenting with PRES of different etiologies, presented here are the findings of 19 patients with available serum magnesium levels (SMLs) during PRES. In the acute phase of PRES, hypomagnesemia was present in all 19 patients in spite of differences in etiology (including immunosuppressive drugs, hypertensive encephalopathy, eclampsia, systemic lupus erythematosus, iatrogenic etiology and unknown). SMLs were within normal ranges prior to PRES and below normal ranges during the first 48h of PRES, with a significant decrease in SMLs during the acute phase. In this retrospective study, constant hypomagnesemia was observed during the acute phase of PRES regardless of its etiology. These results now require larger studies to assess the particular importance of acute hypomagnesemia in PRES and especially the possible need to treat PRES with magnesium sulfate.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Eclampsia; Hypertensive encephalopathy; Hypomagnesemia; Magnesium; Posterior reversible encephalopathy syndrome (PRES)

Mesh:

Substances:

Year:  2016        PMID: 27371132     DOI: 10.1016/j.neurol.2016.06.004

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  16 in total

Review 1.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

2.  Reversible cerebral vasoconstriction syndrome accompanied by hypomagnesemia.

Authors:  Keiichi Hokkoku; Yuichi Furukawa; Junpei Yamamoto; Yudai Uchida; Masahiro Sonoo
Journal:  Neurol Sci       Date:  2018-02-17       Impact factor: 3.307

3.  Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.

Authors:  D Narasimhulu; A Brown; N M Egbert; M Rojas; S Haberman; A Bhutada; H Minkoff; S Rastogi
Journal:  J Perinatol       Date:  2017-10-05       Impact factor: 2.521

4.  Hypertension, seizures, and epilepsy: a review on pathophysiology and management.

Authors:  Sara Gasparini; Edoardo Ferlazzo; Chiara Sueri; Vittoria Cianci; Michele Ascoli; Salvatore M Cavalli; Ettore Beghi; Vincenzo Belcastro; Amedeo Bianchi; Paolo Benna; Roberto Cantello; Domenico Consoli; Fabrizio A De Falco; Giancarlo Di Gennaro; Antonio Gambardella; Gian Luigi Gigli; Alfonso Iudice; Angelo Labate; Roberto Michelucci; Maurizio Paciaroni; Pasquale Palumbo; Alberto Primavera; Ferdinando Sartucci; Pasquale Striano; Flavio Villani; Emilio Russo; Giovambattista De Sarro; Umberto Aguglia
Journal:  Neurol Sci       Date:  2019-05-04       Impact factor: 3.307

Review 5.  Genetics of Magnesium Disorders.

Authors:  Heng Li; Shiren Sun; Jianghua Chen; Goushuang Xu; Hanmin Wang; Qi Qian
Journal:  Kidney Dis (Basel)       Date:  2017-07-05

6.  Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.

Authors:  Slaven Pikija; Georg Pilz; Gerald Gschwandtner; Cornelia Rösler; Konstantin Schlick; Richard Greil; Johann Sellner
Journal:  Front Neurol       Date:  2016-11-07       Impact factor: 4.003

Review 7.  Posterior reversible encephalopathy syndrome.

Authors:  Marlene Fischer; Erich Schmutzhard
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

8.  A Horned Viper Bite Victim with PRES.

Authors:  Ahmed Mustafa Ibrahim; Tarek Talaat ElSefi; Maha Ghanem; Akram Muhammad Fayed; Nesreen Adel Shaban
Journal:  Case Rep Neurol Med       Date:  2017-04-10

9.  Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor?

Authors:  Barbara Birner; Cédric Hirzel; Franca Wagner; Gabriel Waldegg
Journal:  BMJ Case Rep       Date:  2018-01-04

Review 10.  Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging.

Authors:  Redmond-Craig Anderson; Vishal Patel; Nasim Sheikh-Bahaei; Chia Shang J Liu; Anandh G Rajamohan; Mark S Shiroishi; Paul E Kim; John L Go; Alexander Lerner; Jay Acharya
Journal:  Front Neurol       Date:  2020-06-16       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.